Accelerate Diagnostics Inc
NASDAQ:AXDX

Watchlist Manager
Accelerate Diagnostics Inc Logo
Accelerate Diagnostics Inc
NASDAQ:AXDX
Watchlist
Price: 0.04 USD 17.65% Market Closed
Market Cap: $280k

Operating Margin

-301.8%
Current
Improving
by 128%
vs 3-y average of -429.9%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-301.8%
=
Operating Income
$-35.3m
/
Revenue
$11.7m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-301.8%
=
Operating Income
$-35.3m
/
Revenue
$11.7m

Peer Comparison

Country Company Market Cap Operating
Margin
US
Accelerate Diagnostics Inc
NASDAQ:AXDX
280k USD
Loading...
US
Abbott Laboratories
NYSE:ABT
184.5B USD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
180.3B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
136.2B USD
Loading...
US
Stryker Corp
NYSE:SYK
135.2B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
129B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
57.4B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
47.3B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
54B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
46.8B USD
Loading...
US
Resmed Inc
NYSE:RMD
37.4B USD
Loading...

Market Distribution

Lower than 90% of companies in the United States of America
Percentile
10th
Based on 14 112 companies
10th percentile
-301.8%
Low
-4 087 900% — -5.1%
Typical Range
-5.1% — 14.8%
High
14.8% — 1 032 600%
Distribution Statistics
the United States of America
Min -4 087 900%
30th Percentile -5.1%
Median 6%
70th Percentile 14.8%
Max 1 032 600%

Accelerate Diagnostics Inc
Glance View

Market Cap
280k USD
Industry
Health Care

Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. The company is headquartered in Tucson, Arizona and currently employs 220 full-time employees. The firm's in vitro diagnostic platform, the Accelerate Pheno system utilizes genotypic technology to identify (ID), infectious pathogens and phenotypic technology to conduct antibiotic susceptibility testing (AST), which determines whether live bacterial or fungal cells are resistant or susceptible to a particular antibiotic. The company detects and identifies pathogens directly from a single patient sample followed by antimicrobial susceptibility testing based on the identification results. The Accelerate Pheno system features walk-away automation and consists of a fixed instrument and single-use test kit. The Accelerate PhenoTest BC Kit provides ID and AST results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk.

AXDX Intrinsic Value
Not Available
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-301.8%
=
Operating Income
$-35.3m
/
Revenue
$11.7m
What is Accelerate Diagnostics Inc's current Operating Margin?

The current Operating Margin for Accelerate Diagnostics Inc is -301.8%, which is above its 3-year median of -429.9%.

How has Operating Margin changed over time?

Over the last 3 years, Accelerate Diagnostics Inc’s Operating Margin has increased from -569.3% to -301.8%. During this period, it reached a low of -569.3% on Dec 31, 2021 and a high of -301.8% on Jan 1, 2025.

Back to Top